Ecofibre Limited

Informe acción ASX:EOF

Capitalización de mercado: AU$15.4m

Ecofibre Resultados de beneficios anteriores

Pasado controles de criterios 0/6

Los beneficios de Ecofibre han disminuido a una tasa media anual de -69.6%, mientras que en la industria Pharmaceuticals los beneficios crecieron en un 35.4% anualmente. Los ingresos han ido disminuyendo a una tasa media de 11.1% al año.

Información clave

-69.6%

Tasa de crecimiento de los beneficios

-69.2%

Tasa de crecimiento del BPA

Crecimiento de la industria Pharmaceuticals 31.2%
Tasa de crecimiento de los ingresos-11.1%
Rentabilidad financiera-105.7%
Margen neto-151.9%
Última actualización de beneficios30 Jun 2024

Actualizaciones de resultados anteriores recientes

Recent updates

Ecofibre Limited's (ASX:EOF) Price Is Right But Growth Is Lacking After Shares Rocket 30%

Oct 03
Ecofibre Limited's (ASX:EOF) Price Is Right But Growth Is Lacking After Shares Rocket 30%

Ecofibre Limited (ASX:EOF) Not Doing Enough For Some Investors As Its Shares Slump 33%

Aug 19
Ecofibre Limited (ASX:EOF) Not Doing Enough For Some Investors As Its Shares Slump 33%

Benign Growth For Ecofibre Limited (ASX:EOF) Underpins Stock's 41% Plummet

Jun 20
Benign Growth For Ecofibre Limited (ASX:EOF) Underpins Stock's 41% Plummet

Ecofibre Limited (ASX:EOF) Might Not Be As Mispriced As It Looks After Plunging 39%

Apr 24
Ecofibre Limited (ASX:EOF) Might Not Be As Mispriced As It Looks After Plunging 39%

Is Ecofibre (ASX:EOF) Using Too Much Debt?

Apr 13
Is Ecofibre (ASX:EOF) Using Too Much Debt?

Lacklustre Performance Is Driving Ecofibre Limited's (ASX:EOF) 28% Price Drop

Feb 20
Lacklustre Performance Is Driving Ecofibre Limited's (ASX:EOF) 28% Price Drop

Ecofibre Limited's (ASX:EOF) Shares Bounce 30% But Its Business Still Trails The Industry

Jan 03
Ecofibre Limited's (ASX:EOF) Shares Bounce 30% But Its Business Still Trails The Industry

Does Ecofibre (ASX:EOF) Have A Healthy Balance Sheet?

Sep 29
Does Ecofibre (ASX:EOF) Have A Healthy Balance Sheet?

Is Ecofibre (ASX:EOF) A Risky Investment?

Jun 22
Is Ecofibre (ASX:EOF) A Risky Investment?

We Think Ecofibre (ASX:EOF) Has A Fair Chunk Of Debt

Oct 29
We Think Ecofibre (ASX:EOF) Has A Fair Chunk Of Debt

Would Ecofibre (ASX:EOF) Be Better Off With Less Debt?

Mar 05
Would Ecofibre (ASX:EOF) Be Better Off With Less Debt?

One Forecaster Is Now More Bearish On Ecofibre Limited (ASX:EOF) Than They Used To Be

Jun 04
One Forecaster Is Now More Bearish On Ecofibre Limited (ASX:EOF) Than They Used To Be

Ecofibre (ASX:EOF) Has Debt But No Earnings; Should You Worry?

Mar 31
Ecofibre (ASX:EOF) Has Debt But No Earnings; Should You Worry?

Would Shareholders Who Purchased Ecofibre's (ASX:EOF) Stock Year Be Happy With The Share price Today?

Mar 05
Would Shareholders Who Purchased Ecofibre's (ASX:EOF) Stock Year Be Happy With The Share price Today?

We Wouldn't Rely On Ecofibre's (ASX:EOF) Statutory Earnings As A Guide

Feb 07
We Wouldn't Rely On Ecofibre's (ASX:EOF) Statutory Earnings As A Guide

What You Need To Know About Ecofibre Limited's (ASX:EOF) Investor Composition

Jan 04
What You Need To Know About Ecofibre Limited's (ASX:EOF) Investor Composition

Should You Be Excited About Ecofibre Limited's (ASX:EOF) 21% Return On Equity?

Dec 14
Should You Be Excited About Ecofibre Limited's (ASX:EOF) 21% Return On Equity?

Ecofibre's (ASX:EOF) Stock Price Has Reduced 49% In The Past Year

Nov 26
Ecofibre's (ASX:EOF) Stock Price Has Reduced 49% In The Past Year

Desglose de ingresos y gastos

Cómo gana y gasta dinero Ecofibre. Basado en los últimos beneficios reportados, en base a los últimos doce meses (LTM).


Historial de beneficios e ingresos

ASX:EOF Ingresos, gastos y beneficios (AUD Millions)
FechaIngresosBeneficiosGastos G+AGastos de I+D
30 Jun 2428-43223
31 Mar 2428-54183
31 Dec 2330-68163
30 Sep 2331-54184
30 Jun 2331-38185
31 Mar 2330-31206
31 Dec 2230-24227
30 Sep 2230-20217
30 Jun 2230-15216
31 Mar 2230-11196
31 Dec 2130-8186
30 Sep 2129-8185
30 Jun 2129-7194
31 Mar 2133-3203
31 Dec 20361212
30 Sep 20447212
30 Jun 205113212
31 Mar 205113222
31 Dec 195113222
30 Sep 194310211
30 Jun 19366190
31 Mar 19270180
31 Dec 1818-7160
30 Sep 1812-8130
30 Jun 186-9110
30 Jun 171-950

Ingresos de calidad: EOF actualmente no es rentable.

Margen de beneficios creciente: EOF actualmente no es rentable.


Análisis del flujo de caja libre vs. Beneficios


Análisis del crecimiento de los beneficios en el pasado

Tendencia de beneficios: EOF no es rentable, y las pérdidas han aumentado en los últimos 5 años a un ritmo de 69.6% al año.

Acelerando crecimiento: No se puede comparar el crecimiento de los beneficios de EOF en el último año con su promedio de 5 años, ya que actualmente no es rentable.

Beneficios vs. Industria: EOF no es rentable, por lo que resulta difícil comparar el crecimiento de sus beneficios en el último año con el de la industria Pharmaceuticals (46.5%).


Rentabilidad financiera

Alta ROE: EOF tiene una rentabilidad financiera negativa (-105.72%), ya que actualmente no es rentable.


Rentabilidad económica


Rendimiento del capital invertido


Descubre empresas con buenos resultados en el pasado